 |
|
 |
 |

Home > Company Index > Drugs > Drugs - Generic > Watson Pharmaceuticals, Inc.
 |
Watson Pharmaceuticals, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Brazil's Varig posts 1st-half loss of 509 mln reais Aug 14 2001 05:55 AM PDT
D.Telekom surges after upgrade, leading DAX rally Aug 14 2001 04:25 AM PDT
Watson Q2 profits climb 22 percent Aug 14 2001 03:12 AM PDT
Eurostocks weak, D.Telekom sinks, Aegon =2 Aug 10 2001 07:23 AM PDT
Court enjoins Watson from claims about Abbott drug Jul 20 2001 02:21 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Watson Pharmaceuticals makes generic and branded drugs, focusing on niche pharmaceuticals and products that are hard to make. It offers generic versions of such brand-name products as hormone replacement therapies Estrace and Ogen, analgesics Vicodin and Lortab, and ulcer drugs Zantac and Carafate. Watson's branded drug development efforts are focused on nephrology (iron-replacement therapies), women's health (contraceptives and hormone regulators), and general products (antihypertensives, anti-psychotics, and dermatologics). The firm bought Makoff R&D Laboratories and Schein Pharmaceutical to bolster its pipeline.
COMPETITION |
 |
Amgen Inc. (AMGN)
Johnson & Johnson (JNJ)
Merck & Co., Inc. (MRK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 811.50
1-Yr. Sales Growth: 17.7%
Employees: 3,000
Revenue per employee: $270,500.00
KEY PEOPLE |
 |
Allen Y. Chao
CEO
Michael E. Boxer
CFO
CONTACT INFO |
 |
311 Bonnie Circle
Corona, CA 92880
US
Phone: 909-270-1400
Fax: 909-270-1096
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |